Download Mobile App

Featured Video

AACC:
Are Antigens the Answer to Coronavirus Testing?

View Video

Recommended on TradeMed

visit trademed.com

HIV Test
EXACTO® PRO HIV

Sedimentation Rate Analyzer
iSED

Chemiluminescence Analyzer
iFlash 1800

Partner Sites

HospiMedica

MEDICAL FAIR ASIA 2020 Set to Take Place in Singapore from 9 – 11 December 2020

Yale Researchers Use Single-Cell Analysis and Machine Learning to Identify Major COVID-19 Target

Monkeys Demonstrate Immunity Against Novel Coronavirus in New Study

Biogen and Vir Biotechnology Partner to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 Treatment

Study Finds Immunity to Coronavirus May Last Only Six Months with Reinfection Possible

New Purpose-Built COVID-19 LIMS Solution Jump-Starts COVID-19 Testing and Research

By LabMedica International staff writers
Posted on 11 May 2020

Illustration

A new purpose-built COVID-19 laboratory information management system (LIMS) solution can jump-start the ability of laboratories everywhere to enter biospecimens into a biobank and rapidly begin conducting COVID-19-related testing and research.

The new COVID-19 Biobanking Accelerator is built on the LabVantage Solutions, Inc.’s (Somerset, NJ, USA) industry-leading LIMS and Biobanking platforms used by clinical laboratories around the globe. Delivered as a comprehensive Software-As-A-Service (SaaS) solution, the LabVantage COVID-19 Biobanking Accelerator requires no infrastructure investment. Being pre-configured means minimal implementation time is needed with a go-live start possible in less than four weeks.

The LIMS Accelerator includes full biobanking capabilities and COVID-19 extraction and testing workflows with related master data for rapid use. It incorporates multiple protocols defined by the CDC for COVID-19 testing, and it can easily accommodate the addition of standard and customer-determined protocols for testing using a variety of approaches, such as RT-PCR, isothermal nucleic acid amplification and serology.

“Widespread laboratory testing is a critical component in the battle to control the coronavirus pandemic sweeping the globe. At LabVantage, we mobilized our decades of expertise to rapidly deliver a new purpose-built Biobanking LIMS to support COVID-19 testing and research,” said LabVantage CEO John Heiser. “It incorporates our deep knowledge of biobanking along with numerous features designed to make it easy for laboratories to acquire, implement and use the most powerful LIMS on the market for their COVID-19 testing. The LIMS Accelerator is also scalable, an important attribute as testing volumes escalate. Our outstanding service team stands ready to help customers begin using the package almost immediately. We are honored to have the opportunity to contribute to the laboratory testing and research that is critical to controlling and ultimately eliminating this devastating pandemic.”

Related Links:
LabVantage Solutions, Inc.

Latest COVID-19 News

Channels

Clinical Chemistry

view channel

Image: The Element 2 High Resolution, Sector-Field, Inductively Coupled Plasma Mass Spectrophotometer (HR-ICP-MS) (Photo courtesy of Thermo Fisher Scientific).

Molecular Diagnostics

view channel

Image: Micrograph of pancreatic ductal adenocarcinoma (the most common type of pancreatic cancer) (Photo courtesy of Wikimedia Commons)

MicroRNA Biomarker Panel Identifies Patients at Risk for Pancreatic Cancer Metastasis to the Lymph Nodes

A team of cancer researchers has identified a microRNA (miRNA) signature panel that identifies patients at risk for pancreatic cancer metastasis to the lymph nodes. There are usually no early symptoms... Read more

Image: A multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometer (MSI-NACE-MS) (Photo courtesy of McMaster University)

An Analytical Method to Monitor Dietary Fat Intake

An advanced analytical technique was used to determine unequivocally the composition of fats in the diets of pregnant women and female patients suspected of being deficient in certain dietary fats.... Read more

Germline Risk Variants Found in Prostate Cancer Patients

Studies done over the past five years or so have unearthed pathogenic germline variants in some 12% to 17% of men with prostate cancer, and such alterations can impact everything from the treatment options... Read more

Non-Invasive Blood Assay Can Detect Early Colorectal Cancer

Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). In general, colon cancer begins... Read more

Hematology

view channel

Image: The UniCel DxI 800 Access Immunoassay System (Photo courtesy of Beckman Coulter).

Soluble Transferrin Receptor Investigated in Iron Deficiency Anemia

Anemia is a global public health problem and approximately 30% of the world's population suffered from anemia, with children and pregnant women being the most affected. Microcytic hypochromic anemia is... Read more

Image: A blood smear from a patient with microcytosis which may predict underlying cancer even in the presence of normal hemoglobin. Microcytic red blood cells measure 6 μm or less in diameter. The mean corpuscular volume is generally less than 80 fL (Photo courtesy of Sara Beth Fazio, MD).

Microcytosis Is a Risk Marker of Cancer in Primary Care

Microcytosis is a term used to describe red blood cells that are smaller than normal. Anemia is when there are low numbers of properly functioning red blood cells in the body. In microcytic anemia, the... Read more

Image: The CS-2400 is a high performance coagulation station that allows laboratories to perform routine and specialized testing including platelet function tests (Photo courtesy of Sysmex).

Lupus Anticoagulant Prolongs Activated Partial-Thromboplastin Time in COVID-19

Patients with coronavirus disease 2019 (COVID-19) have a profound hypercoagulable state, and complicating venous thrombotic events are common. Abnormalities in coagulation screening measures, including... Read more

Image: The ACL Top 550 hemostasis analyzer (Photo courtesy of Werfen).

Blood Clotting Causes Significant Mortality in COVID-19 Patients

Although the underlying pulmonary pathophysiology remains incompletely understood, severe COVID-19 infection is associated with a marked alveolar inflammatory cell infiltrate, together with a systemic... Read more

Immunology

view channel

Image: The Cytokine Magnetic 30-Plex Panel is specifically designed for quantifying human cytokines, chemokines and growth factors in serum, plasma, and tissue culture supernatant (Photo courtesy of Invitrogen).

Cytokine Signatures of Tertian Malaria Infection Profiled During Pregnancy

Malaria caused by Plasmodium vivax is a neglected tropical disease, especially during pregnancy, of worldwide distribution. P. vivax is a protozoal parasite and a human pathogen. This parasite is the most... Read more

Image: CTL- Immunospot Analyzers come in a wide range of models, each of which is designed to make assay analysis faster, easier, and more accurate than ever before (Photo courtesy of Cellular Technology Limited).

Initial Immune Response After Dengue Virus Infection Identified

Dengue virus (DENV) is a member of the clinically-relevant Flavivirus genus together with Zika virus, yellow fever virus and others. With four distinct serotypes, DENV is thought to infect between 280... Read more

Immune Microenvironment Changes Contribute to Early-Stage Multiple Myeloma

Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Plasma cells help you fight infections by making antibodies that recognize and attack germs. Multiple myeloma... Read more

Image: The Simultest IMK-Lymphocyte is a two-color direct immunoﬂuorescence reagent kit for enumerating percentages of the following mature human leucocyte subsets in erythrocyte-lysed whole blood (Photo courtesy of BDBiosciences).

Immune Responses Evaluated for Tick-Borne Encephalitis

Tick-borne encephalitis (TBE) is an important vector-borne infection of the central nervous system (CNS). The majority of all reported cases of TBE occur in adults. However, TBE should also be included... Read more

Microbiology

view channel

Image: Stenotrophomonas maltophilia colonies on sheep blood agar. Cultivation 48 hours in an aerobic atmosphere, 37 °C (Photo courtesy of microbiologyinpictures).

Global Spread of the Multi-Resistant Pathogen Stenotrophomonas Maltophilia Revealed

Stenotrophomonas maltophilia strains occur in several natural and human associated ecosystems. The bacterium was long regarded as relatively unproblematic, but is now considered to be one of the most feared... Read more

Different Methods Compared for Species Identification of Enterococcus

Biochemical test‐based methodologies are still used in some laboratories for the identification of bacterial isolates, mainly because of the need for the performance of drug susceptibility tests.... Read more

Image: Salmonella are gram-negative, rod-shaped, facultative anaerobic bacteria. Newly developed sensitive and specific assays are able to detect different serotypes of Salmonella, paving the way for rapid serotyping directly from specimens (Photo courtesy of Public Health Image Library, [U.S.] Centers for Disease Control and Prevention)

A Series of Sensitive and Specific DNA-Based Assays Detects and Differentiates Salmonella Serotypes

A team of Australian researchers developed a series of sensitive and specific assays to detect and identify different serotypes (serovars) of Salmonella, a common cause of bacterial foodborne disease worldwide.... Read more

Giemsa Stain Outperforms Urease Test for Helicobacter Pylori Diagnosis

More than 50% of the worldwide population is infected by Helicobacter pylori which is harbored in their upper gastrointestinal tract. Despite having chronic gastritis, most people infected by H.... Read more

Pathology

view channel

Image: Schematic diagram of how the representative tumor sampling method lessens bias in molecular analyses (Photo courtesy of Francis Crick Institute).

Representative Tumor Sampling Method Lessens Molecular Analyses Bias

Over the past decade, clinical scientists have demonstrated the inability of an individual biopsy or formalin-fixed paraffin-embedded (FFPE) block to capture the genetic diversity of a solid tumor.... Read more

$Image: Schematic diagram of circulating tumor DNA (ctDNA) which is found in serum and plasma fractions from blood. The mechanism of ctDNA release is unknown, though apoptosis, necrosis, and active secretion from tumor cells have been hypothesized. Once ctDNA is isolated, it can be sequenced for mutational analysis (Photo courtesy of Rachel June Wong).$